Cargando…
Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1
Triple-negative breast cancer (TNBC) is the most aggressive form of breast cancer, and is associated with a poor prognosis due to frequent distant metastasis and lack of effective targeted therapies. Previously, we identified maternal embryonic leucine zipper kinase (MELK) to be highly expressed in...
Autores principales: | Bollu, Lakshmi Reddy, Shepherd, Jonathan, Zhao, Dekuang, Ma, Yanxia, Tahaney, William, Speers, Corey, Mazumdar, Abhijit, Mills, Gordon B., Brown, Powel H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941974/ https://www.ncbi.nlm.nih.gov/pubmed/31909186 http://dx.doi.org/10.1038/s41523-019-0143-5 |
Ejemplares similares
-
380 The kinesin-like protein Kif11 is essential for the survival of TP53 mutant triple-negative breast cancer cells
por: Lanier, Amanda, et al.
Publicado: (2023) -
p53-independent p21 induction by MELK inhibition
por: Matsuda, Tatsuo, et al.
Publicado: (2017) -
The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression
por: Mazumdar, Abhijit, et al.
Publicado: (2019) -
p53’s Extended Reach: The Mutant p53 Secretome
por: Pavlakis, Evangelos, et al.
Publicado: (2020) -
HELLS Is Negatively Regulated by Wild-Type P53 in Liver Cancer by a Mechanism Involving P21 and FOXM1
por: Schuller, Stefanie, et al.
Publicado: (2022)